Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 70710-1411

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 70710-1411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (A22e9a33 0c4c 4e0c 8eaf 991e66c50753 01)

Chemical structure of Bortezomib, the active ingredient in the described human prescription drug injection form. The diagram shows the molecular arrangement including a boron atom and multiple functional groups characteristic of Bortezomib's structure.*

FDA Label Image

Image (A22e9a33 0c4c 4e0c 8eaf 991e66c50753 02)

A Kaplan-Meier survival curve showing the percentage of patients over time (months) for two groups labeled Vc-MP and MP. The red line represents the Vc-MP group, while the blue dashed line represents the MP group. Patient numbers at risk over time are shown below the x-axis. A p-value from a log-rank test is noted in the lower left corner.*

FDA Label Image

Image (A22e9a33 0c4c 4e0c 8eaf 991e66c50753 03)

A Kaplan-Meier survival curve chart comparing the percentage of patients over time (in months) between two treatment groups labeled Vc-MP and MP. The y-axis represents the percentage of patients, and the x-axis shows time in months up to about 78 months. The chart also includes numbers of patients at risk at various time points below the x-axis and a note about statistical significance with p < 0.05 from a log-rank test.*

FDA Label Image

Image (A22e9a33 0c4c 4e0c 8eaf 991e66c50753 04)

A survival curve chart comparing the proportion of patients over time (in days) between two treatments: Bortezomib and Dexamethasone. The chart shows patient counts at various time points and a p-value indicating statistical significance from a log-rank test.*

FDA Label Image

Image (A22e9a33 0c4c 4e0c 8eaf 991e66c50753 05)

A survival curve chart comparing the proportion of patients over time (days) treated with Bortezomib versus Dexamethasone. The chart includes data points and a p-value indicating statistical significance. Patient counts at various time points are listed below the x-axis, showing larger numbers for Bortezomib versus Dexamethasone at each interval.*

FDA Label Image

Image (A22e9a33 0c4c 4e0c 8eaf 991e66c50753 06)

A Kaplan-Meier survival curve graph showing the percentage of patients over time (months) comparing two treatment groups: VcR-CAP and R-CHOP. The graph includes a log rank test with a p-value of less than 0.001, indicating a statistically significant difference between the groups. A table below the graph shows the number of subjects at risk for each group at various time points up to 60 months.*

FDA Label Image

Image (A22e9a33 0c4c 4e0c 8eaf 991e66c50753 07)

A Kaplan-Meier survival curve chart comparing the percentage of subjects alive over months from randomization between two treatment groups: VcR-CAP (solid line) and R-CHOP (dashed line). The chart includes a hazard ratio (95% CI) of 0.66 (0.51, 0.85). Below the x-axis, numbers at risk for each group are displayed at various time points.*

FDA Label Image

Vial Label (A22e9a33 0c4c 4e0c 8eaf 991e66c50753 08)

Label for Bortezomib for Injection, 3.5 mg/vial lyophilized powder for injection. It indicates intravenous or subcutaneous use. The single-dose vial is manufactured by Zydus Hospira Oncology Pvt. Ltd. and distributed by Zydus Pharmaceuticals USA Inc. The label includes storage instructions, lot, and expiration date fields.*

FDA Label Image

Carton (A22e9a33 0c4c 4e0c 8eaf 991e66c50753 09)

Packaging label for Bortezomib for Injection, 3.5 mg/vial, lyophilized powder for solution by Zydus Pharmaceuticals USA Inc. Indicated for intravenous or subcutaneous use. The label includes reconstitution instructions for subcutaneous and intravenous injections, storage conditions, and manufacturer information. The package contains one single-dose vial.*

FDA Label Image

Carton (inside Flap) (A22e9a33 0c4c 4e0c 8eaf 991e66c50753 10)

This is a packaging carton for BORTEZOMIB, a 1 mg/mL injection powder, lyophilized for solution by Zydus Pharmaceuticals USA Inc. The visible panel provides reconstitution instructions for subcutaneous and intravenous injections, specifying volumes of 0.9% sodium chloride to add for final concentration preparation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.